HEALTH● LOWJul 19 · Jul 19, 2026, 2:45 PM
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
CNBC
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH2h agoPsychology discovered what happens with people who always think everything will get worse, and its relationship with anxiety and depressionClarínHEALTH2h agoPsychology says that searching for flights to distant cities, comparing accommodations, or preparing itineraries for vacations that do not yet have a date is a common activity for many people. Some even organize complete trips that they ultimately never take, but enjoy every stage of the process.ClarínHEALTH2h agoGovernment turning to AI to solve the acknowledged problem of medication shortagesMexico News DailyHEALTH3h agoWATCH: Paris Hilton on navigating life after adult ADHD diagnosisABC News